Early breast cancer screening

The increasing incidence of breast cancer in our country is linked to the rapid growth of our economy, as it is a rich disease, over-nutrition, high-protein fat diet, which keeps estrogen at a high level, and an increase in estrogen is the most important factor in the incidence of breast cancer; high work stress, low fertility, non-fertility, late childbearing and the risk of breast cancer; and a group of people who replace treatment with estrogen, such as those who have long-term estrogen treatment after menopause; those who have tumour family history, breast cancer family history; those who have early menstruation, late menstruation, last mammography or mammography, all at high risk of breast cancer. Breast cancer screening for early detection, diagnosis and treatment is essential for high-risk groups. How old does breast cancer screening start? There are two groups of people who have no family genetic history, which should begin at the age of 40, since the peak age of breast cancer in the country is 45-49 years before the menopause, and unfortunately the treatment of breast cancer before the menopause is less effective than after the menopause; the other group has a family genetic history, where relatives have a genetic history, such as those with a BRCA1/2 mutation, who start mammography at the age of 40. The early detection of breast cancer is also more precise, with four methods, one of which is self-censorship, which is self-tasking, self-censorship of the breast within about one week of the month, as well as a doctor ‘ s access to the mammography, which is examined annually. However, both tests are not accurate, because we advocate early detection of better results, most of which are curable, but very few tumours are detected, so they are not a precise means of screening, although they are not, but they are necessary, because 60 per cent of breast cancer patients are found in kits by their own hands or by their partners, and it is not too late to repair them. Then what is the exact means, which is the ultrasound that is currently being applied in mainland China, which is a feature of mainland China, and few countries around the world have a perfect ultrasound team like mainland China. Because most countries in the world do not have specialist ultrasound doctors, they do that themselves. The other means is a molybdenum target examination, where two molybdenum panels, when caught in the mammogram, can see the position, parcels and calcification in the mammogram through an X-ray. The mammogram, also known as mammograms, is widely used for the screening and diagnosis of various mammograms, using X-rays to project them over the breast, to present them as if they were on a molybdenum-containing base, and then to make an analytical diagnosis of breast images, like breast ultrasound, which is a non-inceptive examination. The molybdenum target can see whether the breast texture is incorrigible, no knots, whether the border is clear or not. The molybdenum target is very sensitive to calcification and its diagnosis is better than ultrasound. Many women in real life still have questions about molybdenum targets, which are answered in turn. That’s the most common problem. Because of the different imaging principles, mammograms and mammograms have their own strengths and weaknesses, the molybdenum targets are stronger at calcium stoves, while ultrasound swollen swollen, and the molybdenum targets and B are so closely aligned that they can be fully diagnosed and leaks can be avoided to the greatest extent possible. How do you choose these two methods? Ultrasound and molybdenum targets are two distinct types of tests, each of which has its own advantages, with ultrasounds better than molybdenum targets, while molybdenum targets are better calcified than ultrasound; ultrasounds are more sensitive to micro-diseases and less specific, and molybdenum targets look at macro-structural distortions and organizational symmetry more than symmetry. So it’s all clinically based on the Mowder Targets Super Screening method. However, since young breast-feeding women are not condensed by mammograms, molybdenum target X-ray penetration and detection rates are low, it is not necessary to undergo a molybdenum test. Females over 40 years of age can combine ultrasound with molybdenum targets, which can be examined once a year before the menopause, without having to do it every year. However, ultrasound suggests that women after age 40 should be examined every year because it is inert and cheap. The treatment of breast cancer. As a result of the development of medical technology, breast-pulsive surgery has taken over, with as little or less damage to the mammography as possible, and has been able to remove the swelling, after which it has been combined with treatment and chemotherapy, with some patients requiring some endocrinological treatment, some patients requiring complementary target-oriented treatment, and, if re-emergence occurs, with the availability of a range of drugs, as well as the improvement of new treatments for bioimmunisation in breast cancer, which will be applied to clinically in the next 10 years. So even with breast cancer around the world, it is considered to be a more therapeutic tumor. Moreover, a new view today is that of tumour survival, that is, that once breast cancer has re-emerged, there is no way we can get rid of the re-emerging tumor and eliminate it, but that we can stop it from growing through some drug-targeting, that is, the patient coexists with the tumor, and that we can maintain normal life. Because the drug targeted for treatment is an unrestricted poison and what is an unrestricted poison is forced to stop because it does not cause physical damage such as damage to the liver, kidney, etc. The non-restricted drug can be administered for life as opposed to a restricted chemotherapy drug. Typical non-restrictive toxicity drugs refer to high blood pressure, diabetes, a life-long drug. He can keep high blood pressure down for a long time, but it bounces back as soon as it stops, so it’s also incurable. However, when the medication is used, blood pressure is kept within normal limits to avoid the complications caused by hypertension, which is the aim of the treatment “to coexist with hypertension”. Then cancer treatment has entered this stage, especially in breast cancer. The problem of breast cancer, which is also preventable, is more easily discovered, and the key is whether we value it, take it seriously, and find it early, even if, unfortunately, it has breast cancer, because most breast cancers can be cured. Its global cure rate is also close to 60 per cent. Therefore, it is not the disease that threatens human life most, and we must dare to confront it.